Neurona Therapeutics, a privately-held clinical-stage biotherapeutics company, focuses on allogeneic neural cell therapies for chronic nervous system diseases. Founded by neuroscientists and stem cell experts at the University of California, San Francisco, Neurona leverages nearly two decades of research. They believe specific neural cell lineages can integrate and repair dysregulated neural circuits. Neurona has a robust regenerative medicine discovery platform and proprietary methods for manufacturing fully-differentiated neuronal, glial, and gene-edited cell therapy candidates. Manufacturing occurs in Neurona’s cGMP facility. Their dedicated team works on advancing first-in-class cell therapy treatments for patients with significant unmet medical needs.